Patents Assigned to Deutsches Krebsforschungszentrum Stiftung des oeffentlichen Rechts Im Neuenheimer Feld 280
  • INTERLEUKIN-4-INDUCED GENE 1 (IL4I1) AND RESPECTIVE METABOLITES AS BIOMARKERS FOR CANCER
    Publication number: 20230032216
    Abstract: The present invention relates to the use of Interleukin-4-induced gene 1 (IL4I1) as well as metabolites as produced by IL4I1 as marker in diagnosis and therapy of cancer and related metastasis and/or resistance to immunotherapy.
    Type: Application
    Filed: December 10, 2020
    Publication date: February 2, 2023
    Applicant: Deutsches Krebsforschungszentrum Stiftung des oeffentlichen Rechts Im Neuenheimer Feld 280
    Inventors: Alexander Boehme, Saskia Trump, Luis Felipe Somarribas Patterson, Ahmed Sadik, Christiane A. Opitz